CANY
JNJ icon

Caxton Associates (New York)’s Johnson & Johnson JNJ Stock Holding History

Caxton Associates (New York)’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-80,000
Closed -$13.2M – 522
2021
Q2 		$13.2M Buy
+80,000
New +$13.2M 1.45% 13

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caxton Associates (New York)'s JNJ Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 18,341 shares — an estimated $2.68M sold.

Caxton Associates (New York) first reported a position in JNJ in Q3 2017 and held it in 19 quarters. The position peaked at $7.3M in Q2 2021. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 18,341 Johnson & Johnson shares in Q3 2024, an estimated $2.68M.
  • Caxton Associates (New York) first reported a position in Johnson & Johnson in Q3 2017 and held it in 19 quarters.
  • Caxton Associates (New York)'s Johnson & Johnson position peaked at $7.3M in Q2 2021.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.